High-Precision Field- Effect Transistor Biosensor for Analyzing Differential Effects of Anti-Cancer Drugs on...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Evaluating anti-cancer drug efficacy requires precise methods to distinguish effects on cancerous versus non-cancerous cells.
• Understanding drug interaction kinetics is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To introduce a high-precision biosensor for independent evaluation of anti-cancer drug effects on RAJI (cancerous) and WIL2S (non-cancerous) cells.
• To quantify drug-induced current changes and cellular entry rates for camptothecin and doxorubicin.
• To validate drug entry rates using flow cytometry.

Main Methods:

• Utilized a novel biosensor based on two-dimensional electron gas sensitivity.
• Analyzed current change and transfer characteristic curves under drug exposure.
• Employed flow cytometry for validation of drug entry rates.

Main Results:

• The biosensor accurately quantifies drug-induced current changes and cellular entry rates.
• Anti-cancer drugs demonstrated a more pronounced impact on tumor cells (RAJI) compared to non-cancerous cells (WIL2S).
• Observed differential effects and interaction speeds of drugs across cell types.

Conclusions:

• The developed biosensor offers high sensitivity for detecting charge variations at ultralow concentrations in high ionic strength fluids.
• This technique enhances understanding of anti-cancer drug specificity and action mechanisms.
• Provides a valuable tool for screening potential anti-cancer drugs and advancing targeted cancer therapies.